Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications

被引:1635
作者
Reddy, L. Harivardhan [1 ,3 ]
Arias, Jose L. [2 ]
Nicolas, Julien [1 ]
Couvreur, Patrick [1 ]
机构
[1] Univ Paris 11, Lab Physicochim Pharmacotechnie & Biopharm, CNRS, UMR 8612,Fac Pharm,IFR 141, F-92296 Chatenay Malabry, France
[2] Univ Granada, Fac Farm, Dept Farm & Tecnol Farmaceut, E-18071 Granada, Spain
[3] Sanofi, Dept Pharmaceut Sci, F-94403 Vitry Sur Seine, France
基金
欧洲研究理事会;
关键词
SUPERPARAMAGNETIC IRON-OXIDE; ACCELERATED BLOOD CLEARANCE; MR CONTRAST AGENTS; EPSILON-CAPROLACTONE NANOPARTICLES; APTAMER-CONJUGATED NANOPARTICLES; SOLID LIPID NANOPARTICLES; IN-VITRO CHARACTERIZATION; DRUG TARGETING TOLERANCE; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS;
D O I
10.1021/cr300068p
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Precise control over the synthesis conditions and surface functionalization of MNPs is crucial because it governs their physicochemical properties, their colloidal stability, and their biological behavior/fate. For pharmaceutical and biomedical purposes, magnetic platforms should possess very small size and narrow size distribution together with high magnetization values. Alternatively, great interest has been recently devoted to the development of metal-doped iron oxides with enhanced magnetic properties. The control over the characteristics and structure of the gel can be easily obtained by fixing the hydroxylation and condensation conditions, as well as the kinetics of the growing process. In particular, the pH, the temperature, the nature and concentration of the salt precursors, and the nature of the solvent have been described to influence the synthesis process. Practically, NP formation occurs when the metal precursor is suspended in polyol and heated up to its boiling point, under stirring.
引用
收藏
页码:5818 / 5878
页数:61
相关论文
共 704 条
  • [71] COLLOIDAL CARRIERS FOR INTRAVENOUS DRUG TARGETING - PLASMA-PROTEIN ADSORPTION PATTERNS ON SURFACE-MODIFIED LATEX-PARTICLES EVALUATED BY 2-DIMENSIONAL POLYACRYLAMIDE-GEL ELECTROPHORESIS
    BLUNK, T
    HOCHSTRASSER, DF
    SANCHEZ, JC
    MULLER, BW
    MULLER, RH
    [J]. ELECTROPHORESIS, 1993, 14 (12) : 1382 - 1387
  • [72] A novel route in bone tissue engineering: Magnetic biomimetic scaffolds
    Bock, N.
    Riminucci, A.
    Dionigi, C.
    Russo, A.
    Tampieri, A.
    Landi, E.
    Goranov, V. A.
    Marcacci, M.
    Dediu, V.
    [J]. ACTA BIOMATERIALIA, 2010, 6 (03) : 786 - 796
  • [73] Boissière M, 2007, J NANOSCI NANOTECHNO, V7, P4649, DOI 10.1166/jnn.2007.001
  • [74] Interaction of Serum Components with Poly(methylmethacrylate) Nanoparticles and the Resulting Body Distribution after Intravenous Injection in Rats
    Borchard, G.
    Kreuter, J.
    [J]. JOURNAL OF DRUG TARGETING, 1993, 1 (01) : 15 - 19
  • [75] The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: Effects of pre-coating with plasma and with serum complement
    Borchard, G
    Kreuter, J
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (07) : 1055 - 1058
  • [76] Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent
    Bourrinet, P
    Bengele, HH
    Bonnemain, B
    Dencausse, A
    Idee, JM
    Jacobs, PM
    Lewis, JM
    [J]. INVESTIGATIVE RADIOLOGY, 2006, 41 (03) : 313 - 324
  • [77] Breulmann M, 1998, ADV MATER, V10, P237, DOI 10.1002/(SICI)1521-4095(199802)10:3<237::AID-ADMA237>3.0.CO
  • [78] 2-6
  • [79] Magnetic order in γ-Fe2O3 nanoparticles:: a XMCD study
    Brice-Profeta, S
    Arrio, MA
    Tronc, E
    Menguy, N
    Letard, I
    Moulin, CCD
    Noguès, M
    Chanéac, C
    Jolivet, JP
    Sainctavit, P
    [J]. JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 288 : 354 - 365
  • [80] Nanoparticles in cancer therapy and diagnosis
    Brigger, I
    Dubernet, C
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651